1,298 material Form 8-K filings that 1,057 companies we cover made with the SEC in April 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Abbott disclosed that a federal court on April 10, 2026 preliminarily approved a proposed settlement of a consolidated shareholder derivative lawsuit against certain current and former directors and officers. The settlement centers on corporate governance commitments, and the defendants deny any wrongdoing; it takes effect only if the court grants final approval at a hearing on June 4, 2026.
Court preliminarily approved the proposed settlement on April 10, 2026, and set a final settlement hearing for June 4, 2026.
Abbott will maintain or adopt governance policies listed in Exhibit A to the settlement stipulation and will commit funds needed to implement them; no cash payment amount is stated.
Lead Plaintiffs' Counsel may request attorneys' fees and expenses of not more than $15.85 million, subject to court approval.
Shareholder objections and notices of intent to appear must be received by May 18, 2026.
Mustang Bio received a Nasdaq notice on April 15, 2026, saying its common stock closed below $1.00 per share for 30 consecutive business days, so it is not in compliance with the minimum bid price rule. The notice has no immediate effect on the stock's listing, but the company has until October 12, 2026 to regain compliance, and there is no assurance it will keep its Nasdaq listing.
Nasdaq notice received April 15, 2026; bid price closed below $1.00 for 30 consecutive business days
Compliance deadline is October 12, 2026, a 180-calendar day grace period
Compliance requires a closing bid price of at least $1.00 for a minimum of ten consecutive business days
Company may be eligible for a second 180-day period or may need a reverse stock split; no decision has been made
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.